Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia

Cytometry Part B - Clinical Cytometry

Volumn 72, Issue 2, 2007, Pages 96-102

  Muñoz, Luz ^a   Lasa, Adriana ^b   Carricondo, Maria T ^b   Hernández, Carmen ^b   Ubeda, Josep ^b   Nomdedéu, Josep F ^b  

^a UDIAT   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

CLL; Flow cytometry; Ig VH mutational gene status; ZAP 70

Indexed keywords

DNA; IMMUNOGLOBULIN; IMMUNOGLOBULIN VH; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; KILLER CELLS, NATURAL; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 33847675496     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20149     Document Type: Article

References (28)

1. Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, Ferrarini M, Kips TJ. Biology and treatment of chronic lymphocytic leukaemia. Hematology 2003;2003:153-175.
2. Rai KR, Patel DV. Chronic lymphocitic leukaemia. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen H, editors. Hematology: Basic Principles and Practice. New York: Churchill Livingstone; 2000. pp 1350-1363.
3. Rai KR, Sawistsky A, Cronkite EP, Chamana AD, Levy RN, Paternack BS. Clinical staging of chronic lymphocytic leukaemia. Blood 1075;46:219-234.
4. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F. A new prognostic classification or chronic lymphocytic leukaemia derived from a multivariate analysis. Cancer 1981;48:198-206.
5. Montserrat E. Classical and new prognostic factors in chronic lymphocytic leukaemia: Where to now? Hematol J 2003;3:7-9.
6. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P. Genomic aberrations and survival in chronic lymphocytic leukaemia. N EnglJ Med 2000;343:1910-19l6.
7. H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
8. H genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000;96:377-379.
9. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, Corcoran MM, Chapman RM, Thomas PW, Copplestone JA, Orchard JA, Hamblin TJ. Multivariate analysis of prognostic factors in CLL: Clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factor. Blood 2002;100:1177-1184.
10. H mutational status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-1416.
11. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;26:893-901.
12. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell 1992;71:649-662.
13. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:l639-l647.
14. Wiestner A, Rosenwald A, Barry T, Wright G, Davis E, Henrickson S, Zhao H, Ibbtson R, Orchard J, Davis Z, Steuer-Stevenson M, Raffeld M, Arthur D, Marti G, Wilson W, Hamblin T, Oscier D, Staudt L. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944-4951.
15. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764-1775.
16. Dürig J, Nuckel H, Cremer M, Fuhrer A, Halfmeyer K, Fandrey J, Moroy T, Klein-Hitpass L, Duhrsen U. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 2003;17:2426-2434.
17. Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein Hitpass L, Sellmann L, Duhrsen U, Durig J. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005;19:750-758.
18. H3-21 genes characterize a new subset of chronic lymphocytic leukaemia. Blood 2002;99:2262-2264.
19. Ghia P, Stamatopoulus K, Belessi C, Moreno C, Stella S, Guida G, Michel A, Crespo M, Laoutaris N, Montserrat E, Anagnostopoulus A, Dighiero G, Passas A, Calagaris-Cappio F, Davi F. Geographic patterns and pathogenetic implications of IGVH gene usage in chronic lymphocytic leukemia: The lesson of the IGHV3-21 gene. Blood 2005;1025:1678-1685.
20. Matutes E, Owusu-Ankomah K, Morilla R1 Garcia Marco J, Houlihan A, Que TH, Catosky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL Leukemia 1994;10:1640-1645.
21. Moreau E, Matutes E, A'Hern R, Morilla A, Morilla R, Owusu-Ankomah K, Seon B, Catovsky D. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol 1997;108:378-382.
22. Cheson BD, Bennet JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National cancer institute-sponsored working groups guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
23. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder HW, Ferrarini M, Chiorazzi N. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-1525.
24. H genes are associated with a more agressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
25. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas P, Hamblin T, Staudt L, Oscier D. ZAP-70 and prognosis in chronic lymphocytic leukemia. Lancet 2004;363:105-111.
26. Gibbs G, Bromidge T, Howe D, Hopkins J, Johnson S. Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory. Clin Lab Haematol 2005;27:258-266.
27. Frater JL, McCarron KF, Hammel JP, Miller ML, Tubbs RR, Pettay J, His ED. Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Am J Clin Pathol 2001;116:655-664.
28. Matutes E, Polliack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Haematol 2000;4:22-47.